Home › Triple-Negative Breast Cancer › Oregon › Portland

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Portland, OR

9 pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Portland (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

Oregon Health & Science University (OHSU), Portland

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Nagre-recruitPhase 3

Providence Portland Medical Center ( Site 0116), Portland
Providence Oncology and Hematology Care Clinic - Westside ( Site 0126), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06393374

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Providence Portland Medical Center, Portland
Providence St. Vincent Medical Center, Portland
Local Institution - 0052, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06618287

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

Nagre-recruitPhase 2

Providence Portland Cancer Institute - Franz Clinic, Portland
Providence St. Vincent Medical Center, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06353997

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Nagre-recruitPhase 3

Oregon Health & Science University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05633654

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Providence Cancer Center Oncology and Hematology Care- Eastside, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04895709

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

Compass Oncology - Rose Quarter, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Nagre-recruitPhase 2

Oregon Health & Science Institute (OHSU), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT01042379

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa Portland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.